The HCPLive Insights page is a resource for professional video interviews with leading clinical experts and investigators across all specialties of medicine.
Dr Stein Gold discusses how plaque psoriasis impacts a patient’s quality of life, even when smaller body surface areas are affected. She reviews data on systemic therapies from head-to-head trials, as well as recent data in patients with moderate plaque psoriasis.
An expert nephrologist discusses the burden and standard of care for patients with immunoglobulin A nephropathy (IgAN), new and emerging targeted immunomodulating therapies, and considerations for treatment.
An expert rheumatologist reviews current treatment options in rheumatoid arthritis, focusing on tumor necrosis factor-α inhibitors (TNFi) and the molecular signature response classifier (MSRC) test.
Dr Peter Kaiser, an ophthalmologist, provides an overview of biosimilars, the regulatory pathway for their approval, and how biosimilars can aid in providing quality care to patients. Dr. Kaiser shares data with ranibizumab biosimilars in ophthalmology and discusses key differences between biosimilar and reference product studies.
Expert rheumatologist, Kostas N. Botsoglou, MD provides an overview of the current therapeutic landscape for Systemic Autoimmune Rheumatic Diseases (SARDs) and discusses potential treatments on the horizon.
The HCPLive Insights series, “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth,” put on in partnership with Cure SMA, features Diana Castro, MD, and Garey H. Noritz, MD, who offer tips and demonstrations for screening and diagnosing SMA via telehealth. Additionally, resources provided by Cure SMA are outlined for families and clinicians who suspect SMA or have a patient diagnosed with SMA.